Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.2784
Delayed Data
As of 3:58pm ET
 +0.0034 / +1.24%
Today’s Change
0.21
Today|||52-Week Range
2.97
-83.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization160.0K41.0K35.0K161.0K
 
 
 
 
 
 
Operating ExpensesGross Income-160.0K-41.0K-35.0K-161.0K
 
 
 
 
 
General Expenses8.5M7.9M9.2M10.8M
 
 
 
 
 
Research And Development7.0M6.1M7.7M7.5M
 
 
 
 
 
Total Operating Expenses8.7M7.9M9.3M11.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.7M-7.9M-9.3M-11.0M
 
 
 
 
 
Extraordinary Credit9.0M1.7M0.003.3M
 
 
 
 
Extraordinary Charge0.000.00-407.0K0.00
 
 
Other Expenses-28.0K-43.0K-11.0K-43.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income313.0K-6.3M-9.7M-7.7M
 
 
 
 
 
Preferred Dividend0.000.000.00-1.5M
 
 
Net Income313.0K-6.3M-9.7M-7.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.1M10.9M13.2M22.2M
 
 
 
 
 
Shares To Calculate EPS Diluted10.1M10.9M13.2M22.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.03-$0.58-$0.73-$0.42
 
 
 
 
 
EPS Diluted$0.03-$0.58-$0.73-$0.42